Search for: rheumatoid arthritis methotrexate autoimmune disease biomarker gene expression GWAS HLA genes non-HLA genes
| ID | PMID | Title | PublicationDate | abstract |
|---|---|---|---|---|
| 2683781 | Associations of the skeletal and immune systems. | 1989 Sep | Certain disorders of the immune system seem to be associated with skeletal defects. The association was first recorded by McKusick et al. (Bulletin of the Johns Hopkins Hospital 116:285-326, 1964). A number of relationships between lymphocytes and osteocytes can be proposed. These include a common environment for development, common metabolic needs and effects upon osteocytes by products (cytokines) elaborated from lymphocytes or monocytes during immune responses. Thus, bony defects of varying degrees of severity are seen in short-limb dwarfs, cartilage-hair hypoplasia, and adenosine deaminase (ADA) deficiency. Cytokine activation of osteoclasts accounts for the lytic lesions seen in malignancies and the excessive bone resorption which accompanies autoimmune disorders such as rheumatoid arthritis. Correction of primary immune deficiency is accomplished by bone marrow transplantation. If the bony abnormality is subtle (as in some cases of ADA deficiency) the skeletal problem is resolved; if the bone defect is major as in short-limb dwarfism, no improvement is seen. | |
| 2787634 | Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cart | 1989 Jul 14 | We show that purified human transforming growth factor-beta (1-10ng/ml) inhibits interleukin 1-stimulated loss of proteoglycan from cartilage in vitro. Inhibition is incomplete, as interleukin 1 retains the ability to cause a dose dependent stimulation of proteoglycan release in the presence of high levels of transforming growth factor-beta (100ng/ml) although both basal and interleukin 1-stimulated levels can be reduced by up to 50 per cent. This observation, together with its ability to stimulate proteoglycan synthesis and to stimulate proteinase inhibitor production, suggests a possible role for transforming growth factor-beta in limiting cartilage proteoglycan loss in inflammatory conditions such as rheumatoid arthritis. | |
| 2491403 | [Use of non-steroidal antiinflammatory drugs in specialty polyclinic practice]. | 1989 | A retrospective investigation of the prescription of nonsteroidal antiinflammatory drugs (NSA) was performed in the Rheumatologic out-patient-institute in Zagreb, including 1000 patients of both sexes, aged 20-70 years. 500 outpatients were treated by NSA during 1987 and 1989 respectively for lumbosacral syndrome, rheumatoid arthritis, ankylosing spondylitis and coxarthrosis. The kind of NSA as well as the registered side-effects were analysed from case histories. During 1987, NSA were applied to 365 (73%) and during 1989 to 390 (78%) of the 500 patients. In both groups a phenyl-acetic acid derivative (diclophenac) was most often applied, followed by propionic acid derivatives and oxycams. The most rarely applied drugs were indol-acetic acid derivatives. Pyrazolones were given only to 2 patients with an acute flare of ankylosing spondylitis in 1987. A gastro-duodenal ulcer was the absolute counterindication for this kind of treatment. The number of side-effects in this investigation was relatively small (6.5% in 1987 and 5% in 1989), probably because this investigation was a retrospective one. The most common among them appeared in the gastro-intestinal tract. | |
| 3065702 | [Human leukocyte elastase]. | 1988 Nov | This article reviews some properties of human leucocyte elastase. This 30 kDa glycoprotein formed of 218 amino acid residues, is a serine proteinase which cleaves proteins at Val-X, Ala-X, Leu-X or Met-X bonds. Leucocyte elastase solubilizes fibrous elastin and also degrades other extracellular matrix proteins. It hydrolyses and inactivates a number of plasma proteins. Synthetic substrates are more convenient than elastin to measure elastase activity. A large number of natural and synthetic inhibitors of leucocyte elastase have been described. The former include alpha 1-proteinase inhibitor or alpha 1-antitrypsin, inter-alpha-inhibitor, alpha 2-macroglobulin, bronchial and cervical mucous inhibitor and a number of animal and plant proteins. Numerous synthetic inhibitors with therapeutic potentials have been designed. The efficiency of an inhibitor depends, among others, upon its rate of association with the enzyme and upon the stability of the enzyme-inhibitor complex. Elastase probably plays a physiological function in neutrophil migration, phagocytosis and tissue remodeling. It apparently plays a pathological role in pulmonary emphysema, rheumatoid arthritis, infections and inflammation. The pathogenic role of leucocyte elastase is best understood in emphysema. | |
| 3056328 | The development of physiatry before 1950. | 1988 Oct | The early development of physiatry as a specialty must be credited to a small group of men who were literally giants in the roles they played in the evolution of physiatry and of the American Academy of PM&R. Of those very early leaders, John S. Coulter, Frank H. Krusen, William Bierman, and Richard Kovacs stand out for their inspirational and conceptual leadership regarding the potentials of physiatry. The field will forever be indebted to Walter J. Zeiter for his administrative and executive abilities. Howard A. Rusk earned the approbation "Father of Rehabilitation Medicine" when he first demonstrated that rehabilitation of the ill and injured made it possible to restore meaning to life and at the same time reduce the duration and costs of disability. Finally, it is important that we appreciate the role George C. Deaver played as the progenitor, or perhaps "Grandfather" of physical medicine and rehabilitation. Although he was not an organization man--and in fact appears to have shunned them--he was the first physiatrist to use all the available tools of PM&R to rehabilitate the spinal cord injured, the patients with cerebral palsy, with the muscular dystrophies, with multiple sclerosis, and rheumatoid arthritis. At a time when these patients were being rejected and discarded as permanently disabled, Deaver was accepting them and patiently working with them to achieve the best possible outcomes through rehabilitation. And now, on to the 1950s. . . | |
| 3365912 | Hepatic safety of two analgesics used over the counter: ibuprofen and aspirin. | 1988 May | We evaluated the potential hepatic toxicity of ibuprofen, aspirin, and oxaprozin in 1468 patients with rheumatoid arthritis and osteoarthritis by slightly modifying an algorithm that was developed to evaluate the drug relatedness of renal toxicity associated with therapeutic doses of these agents in the same population. Ibuprofen proved to be the safest of these nonsteroidal antiinflammatory drugs; it was associated with no AST elevation that was considered probably drug related as determined by application of the algorithm to laboratory values and information from case report forms. The frequency of probably drug-related AST elevations was highest (5%) with aspirin; with oxaprozin, an investigational nonsteroidal antiinflammatory drug, the incidence (3%) fell between that for the other two agents. Thus our findings on the hepatic safety of ibuprofen are consistent with those in the medical literature. | |
| 3349247 | Parasymphyseal and associated insufficiency fractures of the pelvis and sacrum. | 1988 Feb | Eleven post-menopausal women presenting with a parasymphyseal insufficiency fracture of the pubis are reported. The plain radiographs showed delayed healing with a mixed lytic and sclerotic area developed at the fracture site simulating a malignant lesion. Aetiological factors included post-menopausal osteoporosis, rheumatoid arthritis and steroid therapy, previous hip replacement and pelvic radiotherapy. Ten patients had concomitant fractures of the pelvis, including nine with sacral fractures. These were all initially missed on presentation because of the subtle radiographic signs of a longitudinal band of sclerosis, usually bilaterally, in the sacral ala. Bone scanning was shown to be the most sensitive technique in detecting the sacral fractures by demonstrating increased uptake in the sacral ala as well as the other fractures of the pelvis. Computed tomography in three cases was helpful in confirming the presence of fractures and excluding the possibility of malignancy. | |
| 3090278 | Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) th | 1986 Aug | Cyclophosphamide is a well established cytotoxic drug used in the treatment of lymphoproliferative disorders, certain solid tumors, and nonneoplastic disorders such as nephrotic syndrome, systemic lupus erythematosus and rheumatoid arthritis. Hemorrhagic cystitis can be a complication of this drug varying between two and 40 per cent. Misoprostol, which is a synthetic prostaglandin E1 analog, was found to significantly decrease the histological damage to the bladder from cyclophosphamide. Male rats receiving misoprostol in conjunction with cyclophosphamide were found to have a reduction in ulceration, inflammation and edema of the bladder walls as compared to those treated with cyclophosphamide alone. | |
| 3517324 | Neurofilament antibodies in systemic lupus erythematosus. | 1986 Feb | Autoantibodies against neuronal antigens occur in sera of patients with systemic lupus erythematosus (SLE). These antibodies may have significance in the pathogenesis of neurological complications of SLE. However, the neuronal structures containing the corresponding autoantigens are poorly known. In our study we assayed circulating antibodies against defined neuronal components--neurofilaments--by an enzyme-linked immunosorbent assay (ELISA) using purified neurofilament polypeptides as targets. Circulating neurofilament antibodies (anti-NF) of IgG class were detected in 21% of 28 patients with SLE and in 6% of 17 patients with rheumatoid arthritis and in none of the 14 patients with primary sicca syndrome and 40 blood donors. The presence of anti-NF could also be confirmed by the indirect immunofluorescence technique using frozen sections of rat spinal cord. In one serum, anti-NF cross reacted with vimentin type of intermediate filaments. The antibodies bound both to the 70 kilodalton and the 200 kilodalton polypeptides of neurofilaments as judged by the immunoblotting technique. Two of 6 anti-NF positive patients had neurological complications. | |
| 1668758 | An assessment of the interaction between human neutrophils, hydroxyapatite and dichloromet | 1991 Jun | The potentially destructive effects of neutrophils, following particulate stimulus such as by hydroxyapatite (HA) crystals, may be pertinent to the progression of some inflammatory diseases, including rheumatoid arthritis. This study was designed to examine the interaction between pure hydroxyapatite particles and human neutrophil granulocytes by transmission electron microscopy and chemiluminescence (CL). The influence of dichloromethylene bisphosphonate (clodronate) in this model was investigated. Neutrophils convincingly phagocytosed HA particles within 15 min and a high CL response was elicited by the zymosan stimulated CL reaction. Clodronate alone appeared to have little effect on the cell morphology or CL. When HA was combined with clodronate, phagocytosis was more rapid, and the zymosan-stimulated CL was 50% of that of the HA group. The results demonstrate neutrophil phagocytosis of HA particles and subsequent cellular activation, which may play a role in the pathogenesis of tissue damage and suggest that the anti-inflammatory role of clodronate should be further investigated. | |
| 1841992 | Immunomodulating Chinese herbal medicines. | 1991 | Traditional Chinese medicine always pays close attention to the strengthening of the patient's general resistance against illness, there are many Chinese herbs used for thousands of years are considered as tonics. Animal experiments and modern clinical trails have shown that quite a number herbs are immunologically active, and most of the tonics are excellent immunomodulating agents, such as polysaccharides or saponins isolated from Astragalus mongholicus, Acanthopanax senticosus and Panax notoginseng, which stimulated macrophages, promoted antibody formation, activated complement and increased T lymphocyte proliferation. Moreover, some of them were proved to be anti-irradiative and protected animals from liver intoxications. On the other hand, some anti-inflammative or anti-pyretic herbs such as Tripterygium wilfordii, Aconitum and Artemisiae species were proved to have immunosuppressive principles, some of them were now used clinically for the treatment of rheumatoid arthritis, chronic nephritis, systemic lupus erythematosis and various skin disorders. Pharmacological studies revealed that they have depressant effect on most of the humoral-immunity but not on the cell-mediated immunity. Some of them stimulated adrenal cortex functions and prolonged the survival time of transplanted allograft tissues. | |
| 2197998 | The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recomb | 1990 Jun | Loss of connective tissue integrity occurs in many disease processes, including rheumatoid arthritis and osteoarthritis. Although there is a high incidence of these diseases in the developed world, there is no treatment that prevents the tissue damage that occurs. Several lines of evidence suggest that uncontrolled connective tissue metalloproteinase activity is responsible for the damage, and as a consequence the inhibition of these enzymes has become the target for therapeutic intervention. Several connective tissue metalloproteinases, including collagenase, stromelysin, and gelatinase, together with tissue inhibitors of metalloproteinases (TIMPs), have been described. Because of difficulties in isolating the metalloproteinases in sufficient quantity as pure separate enzymes, however, very little knowledge has accumulated about their detailed biochemistry. For similar reasons the way in which TIMPs inhibit tissue metalloproteinases is not yet fully understood. In this article it is shown how cloning metalloproteinase and TIMP cDNAs can provide information about the structure of these enzyme and inhibitor families and how the cDNAs can be used to generate recombinant cell lines from which enzymes and inhibitors can be readily purified for further studies. | |
| 2094619 | [The heart in various connective tissue diseases]. | 1990 May | In this study is presented the experience of 294 patients with different connective tissue diseases such as: a) rheumatoid arthritis, b) systemic lupus erythematosus, c) ankylosing spondylitis, d) progressive systemic sclerosis, e) dermatomyositis-polymyositis and f) mixed connective tissue disease. All these patients were studied prospectively during the last eight years through non-invasive methods to detect cardiovascular complications. The connective tissue diseases can provoke inflammation and fibrosis in any of the diverse cardiac structures, with the consequent complications. These alterations are frequent, with a high degree of morbidity, and have a direct relationship with the severity and chronicity of the primary connective tissue disease. Some of these patients respond favorably to cardiological and anti-inflammatory management, while others are refractory to such treatments. The prognosis of the observed complications in these patients depends in great part on the development of the basic rheumatic disease. This kind of patients should be studied systematically from the cardiological view point, so as to detect these complications as early as possible. | |
| 2369142 | Crystalline and amorphous gold in chrysiasis. | 1990 | Skin biopsy specimens from five patients (three females and two males) treated parenterally with gold were investigated using transmission electron microscopy. X-ray microanalysis and electron diffraction were used to determine the dermal heavy metal content. Additional sections were stained for light microscopic examination. The amount of elemental gold administered to the patients over a period of years to alleviate rheumatoid arthritis lay between a minimum of 4.0 g and a maximum of 10.0 g. In one and the same patient dermal histiocytic gold aggregations in sun-exposed areas of skin displayed a different pattern and divergent physiochemical states from the gold deposits in non-UV-exposed skin, where aurosome-like amorphous formations are found in the cells of the upper dermis. Additional spherical particles are associated predominantly with phagolysosomes in melanophages beneath solar-irradiated epidermis. Convergent beam electron diffraction proves the crystalline nature of the spherical auriferous deposits. The occurrence of skin rash was not related to different physicochemical states of the precious metal. | |
| 2768299 | Aggressive granulomatous lesions after hip arthroplasty. | 1989 Aug | We reviewed 19 patients who presented with aggressive granulomatosis around the femoral stem after hip replacement. All had experienced stress pain and had required revision arthroplasty on average 8.8 years after the primary operation. Fifteen patients were men and four were women; none had rheumatoid arthritis. One patient had an uncemented Moore hemiprosthesis; the others all had cemented total hip replacements. When first detected, the granulomatous lesions were multifocal in 13 patients. The first granuloma was in the region of the lesser trochanter in 10, and near the tip of the stem in only two. Speed of growth varied but on average there was doubling of the area on anteroposterior films in 2.2 years (range 6 months to 4.6 years). Aggressive granulomatous lesions in replaced hips are a distinct condition, different from simple loosening or infection; the lesions may grow rapidly, so revision surgery is indicated soon after diagnosis. | |
| 2767535 | [Spontaneous rupture of the extensor pollicis longus]. | 1989 Jul | A review of the literature is followed by the analysis of a series of forty-four patients who were treated by extensor indicis transposition. Twenty-five patients could be reached for a clinical follow-up examination, nine further patients were interviewed by telephone; of the remaining ten patients, seven could not be reached and three had died. Excluded from the series were patients with rheumatoid arthritis. Results were evaluated according to the scheme suggested by Geldmacher and coworkers. According to their evaluation scheme, we can report fourteen excellent, eight good, three satisfactory, and no bad results. Subjectively, the results were even better, with twenty-eight patients reporting excellent, four good, and two satisfactory results, including those nine patients contacted by telephone only. Strength of extension of the index finger was not diminished after the extensor indicis transposition when all fingers were extended simultaneously. However, there was a deficit of extension in a few cases when the remaining fingers were clenched to a fist. This indicates that an alternative method should probably be recommended in patients with professions where individual extension of the index finger is of paramount importance. It is also suggested that additional functional tests, convertible into score points, might render the evaluation more realistic than measurements only. Inclusion of these additional functional tests might also give an explanation for the discrepancy between patients' subjective results and those as a result of measurement only. | |
| 2657967 | [Psychoimmunology]. | 1989 Mar 28 | Psychoneuroimmunology, an interdisciplinary field of research, is concerned with the interactions between the central nervous system, the endocrine system and the immune system. In this survey the importance of psychosocial factors is illustrated by means of a number of studies reviewed from the literature: 1. Psychosocial factors related to illness (except aids): In animal experiments it could be shown that the effects of aversive stimulation on tumor growth were dependent on the type and manner of application of the stressors. The influence of personality factors and psychological states on the course and possibly also on the susceptibility to illness was frequently confirmed with regard to upper respiratory infections, coronary artery disease, rheumatoid arthritis and cancer. 2. Psychosocial factors related to changes in immunity: Changes in immunity could be demonstrated relating to bereavement of close relatives as well as in mental illness. In spite of immunologic abnormalities found in the various diseases the importance of the aforementioned immunosuppression on possible subsequent onset of illness is not yet clarified. The fact that we can experimentally strengthen or weaken the immune system by means of psychological methods offers a further possibility to influence the course and prognosis of various diseases by means of psychologically induced changes in immunity. | |
| 2666138 | Multiple publication of reports of drug trials. | 1989 | Fourty-four multiple publications of 31 comparative trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis were examined for mutual agreement. Thirty-two of the papers were published in the same language as the primary version. Important discrepancies were seen in 14 trials, involving description of the study design in two, exclusion of protocol violators in two, inconsistency in the number of effect variables in five, in the number of side-effects in five, and in the significance level in one. In three articles the conclusion became more favourable for the new drug with time. Only half of the trials had the same first author and number of authors. For six trials, multiple publication was difficult to detect. Adherence to the manuscript guidelines published by the International Committee of Medical Journal Editors should diminish the risk of inflated meta-analyses, reference lists and curricula vitae, and inexplicable discrepancies in articles based on the same data. | |
| 3072353 | Ketoprofen: the European experience. | 1988 Dec | An overview of European experience with ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic properties, from the time of its marketing in 1973 until the present is presented. Orally administered ketoprofen (200 mg/day) has been proven effective in treating rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Furthermore, several alternate dosage forms, including intramuscular injection for relief of acutely painful conditions, suppositories, two slow-release forms (a sustained-release tablet [IBP 200] and a controlled-release capsule [Oruvail] ), and a topical gel for local treatment of certain superficial conditions and minor rheumatologic disease are available. The safety of ketoprofen has also been proven in several European postmarketing surveillance studies and more importantly, by French and British drug monitoring data. Ketoprofen was rated as one of the safest NSAIDs available in the United Kingdom (UK) by the Committee on the Safety of Medicine in 1986. For incidence of gastrointestinal complaints per million prescriptions, ketoprofen ranked seventh among 19 NSAIDs in its first five years of marketing in the UK. Ketoprofen has been associated with a very low incidence of serious renal, hepatic, or cutaneous reactions. Thus ketoprofen, in 15 years of marketed use in Europe, has proven to be an effective anti-inflammatory and analgesic agent with an excellent safety profile and several convenient dosage forms. | |
| 3069424 | Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflamma | 1988 Nov | Diclofenac sodium is a nonsteroidal antiinflammatory drug (NSAID) that has been used in 120 countries since its introduction in Japan in 1974. It is currently the eighth largest-selling drug and the most frequently used NSAID in the world. Diclofenac, a phenylacetic acid derivative, is a potent inhibitor of cyclooxygenase enzyme activity, and may also interact with the lipoxygenase enzyme pathway, and with the release and reuptake of arachidonic acid. Diclofenac is almost completely absorbed, highly protein-bound, penetrates well into synovial fluid, and is extensively metabolized. Comparative studies have shown that diclofenac is at least equivalent in efficacy to aspirin and other NSAID when used for the treatment of rheumatic diseases such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Diclofenac also possesses potent analgesic properties. Clinical trials suggest that diclofenac has a favorable side-effect profile, excellent patient tolerability, and a lower patient dropout rate when compared with aspirin and other NSAID. |